{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:41:33Z","timestamp":1777102893692,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R231-A13964"],"award-info":[{"award-number":["R231-A13964"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R231-A13964"],"award-info":[{"award-number":["R231-A13964"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,5,18]]},"DOI":"10.1038\/s41416-025-02974-x","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T13:15:23Z","timestamp":1741439723000},"page":"828-836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Statin use and risk of breast cancer among women with benign breast disease: a Danish nationwide cohort study"],"prefix":"10.1038","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0774-4259","authenticated-orcid":false,"given":"Charlotte","family":"Skriver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9738-2284","authenticated-orcid":false,"given":"Deirdre","family":"Cronin-Fenton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Signe","family":"Borgquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Hansen Viuff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Alkner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7515-3130","authenticated-orcid":false,"given":"Lisa","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Vibeke","family":"L\u00e6nkholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Manjer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ylva","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren","family":"Friis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"Mellemkj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"key":"2974_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2974_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","volume":"101","author":"DJ Maron","year":"2000","unstructured":"Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation. 2000;101:207\u201313.","journal-title":"Circulation"},{"key":"2974_CR3","doi-asserted-by":"publisher","first-page":"b2376","DOI":"10.1136\/bmj.b2376","volume":"338","author":"JJ Brugts","year":"2009","unstructured":"Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Westendorp RG, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ. 2009;338:b2376.","journal-title":"BMJ"},{"key":"2974_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111858","volume":"141","author":"JA Duarte","year":"2021","unstructured":"Duarte JA, de Barros ALB, Leite EA. The potential use of simvastatin for cancer treatment: a review. Biomed Pharmacother. 2021;141:111858.","journal-title":"Biomed Pharmacother"},{"key":"2974_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.5414\/CPP42695","volume":"42","author":"AO M\u00fcck","year":"2004","unstructured":"M\u00fcck AO, Seeger H, Wallwiener D. Inhibitory effect of statins on the proliferation of human breast cancer cells. Int J Clin Pharmacol Ther. 2004;42:695\u2013700.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2974_CR6","doi-asserted-by":"publisher","first-page":"8707","DOI":"10.1158\/0008-5472.CAN-05-4061","volume":"66","author":"MJ Campbell","year":"2006","unstructured":"Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, et al. Breast cancer growth prevention by statins. Cancer Res. 2006;66:8707\u201314.","journal-title":"Cancer Res"},{"key":"2974_CR7","doi-asserted-by":"publisher","first-page":"11314","DOI":"10.1074\/jbc.M110.193714","volume":"286","author":"CC Mandal","year":"2011","unstructured":"Mandal CC, Ghosh-Choudhury N, Yoneda T, Choudhury GG, Ghosh-Choudhury N. Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44. J Biol Chem. 2011;286:11314\u201327.","journal-title":"J Biol Chem"},{"key":"2974_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.574068","volume":"11","author":"L Yin","year":"2020","unstructured":"Yin L, He Z, Yi B, Xue L, Sun J. Simvastatin suppresses human breast cancer cell invasion by decreasing the expression of pituitary tumor-transforming gene 1. Front Pharmacol. 2020;11:574068.","journal-title":"Front Pharmacol"},{"key":"2974_CR9","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1111\/cas.13570","volume":"109","author":"JC Wang","year":"2018","unstructured":"Wang JC, Li XX, Sun X, Li GY, Sun JL, Ye YP, et al. Activation of AMPK by simvastatin inhibited breast tumor angiogenesis via impeding HIF-1\u03b1-induced pro-angiogenic factor. Cancer Sci. 2018;109:1627\u201337.","journal-title":"Cancer Sci"},{"key":"2974_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/joim.12806","volume":"284","author":"S Borgquist","year":"2018","unstructured":"Borgquist S, Bjarnadottir O, Kimbung S, Ahern TP. Statins: a role in breast cancer therapy? J Intern Med. 2018;284:346\u201357.","journal-title":"J Intern Med"},{"key":"2974_CR11","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1097\/CAD.0000000000001151","volume":"33","author":"G Zhao","year":"2022","unstructured":"Zhao G, Ji Y, Ye Q, Ye X, Wo G, Chen X, et al. Effect of statins use on risk and prognosis of breast cancer: a meta-analysis. Anticancer Drugs. 2022;33:e507\u2013e518.","journal-title":"Anticancer Drugs"},{"key":"2974_CR12","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00404-017-4533-3","volume":"296","author":"MM Islam","year":"2017","unstructured":"Islam MM, Yang HC, Nguyen PA, Poly TN, Huang CW, Kekade S, et al. Exploring association between statin use and breast cancer risk: an updated meta-analysis. Arch Gynecol Obstet. 2017;296:1043\u201353.","journal-title":"Arch Gynecol Obstet"},{"key":"2974_CR13","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/s41416-018-0252-1","volume":"119","author":"R Langballe","year":"2018","unstructured":"Langballe R, Cronin-Fenton D, Dehlendorff C, Jensen MB, Ejlertsen B, Andersson M, et al. Statin use and risk of contralateral breast cancer: a nationwide cohort study. Br J Cancer. 2018;119:1297\u2013305.","journal-title":"Br J Cancer"},{"key":"2974_CR14","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.3390\/ijerph19052625","volume":"19","author":"M Rom\u00e1n","year":"2022","unstructured":"Rom\u00e1n M, Louro J, Posso M, Vidal C, Bargall\u00f3 X, V\u00e1zquez I, et al. Long-term risk of breast cancer after diagnosis of benign breast disease by screening mammography. Int J Environ Res Public Health. 2022;19:2625.","journal-title":"Int J Environ Res Public Health"},{"key":"2974_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa044383","volume":"353","author":"LC Hartmann","year":"2005","unstructured":"Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229\u201337.","journal-title":"N Engl J Med"},{"key":"2974_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390.","journal-title":"Clin Epidemiol"},{"key":"2974_CR17","first-page":"798","volume":"46","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Schmidt SA, Wallach-Kildemoes H, S\u00f8rensen HT, Hallas J, Schmidt M. Data resource profile: The Danish National Prescription Registry. Int J Epidemiol. 2017;46:798\u2013798f.","journal-title":"Int J Epidemiol"},{"key":"2974_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1403494810393562","volume":"39","author":"ML Gjerstorff","year":"2011","unstructured":"Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39:42\u201345.","journal-title":"Scand J Public Health"},{"key":"2974_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2147\/CLEP.S99457","volume":"8","author":"P Christiansen","year":"2016","unstructured":"Christiansen P, Ejlertsen B, Jensen MB, Mouridsen H. Danish Breast Cancer Cooperative Group. Clin Epidemiol. 2016;8:445\u20139.","journal-title":"Clin Epidemiol"},{"key":"2974_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/CLEP.S9908","volume":"2","author":"R Erichsen","year":"2010","unstructured":"Erichsen R, Lash TL, Hamilton-Dutoit SJ, Bjerregaard B, Vyberg M, Pedersen L. Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clin Epidemiol. 2010;2:51\u201356.","journal-title":"Clin Epidemiol"},{"key":"2974_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1403494810394715","volume":"39","author":"VM Jensen","year":"2011","unstructured":"Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39:91\u20134.","journal-title":"Scand J Public Health"},{"key":"2974_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, S\u00f8rensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541\u20139.","journal-title":"Eur J Epidemiol"},{"key":"2974_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/1403494811399957","volume":"39","author":"LT Blenstrup","year":"2011","unstructured":"Blenstrup LT, Knudsen LB. Danish registers on aspects of reproduction. Scand J Public Health. 2011;39:79\u201382.","journal-title":"Scand J Public Health"},{"key":"2974_CR24","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/ije\/dyw116","volume":"45","author":"M Schmidt","year":"2016","unstructured":"Schmidt M, Hallas J, Laursen M, Friis S. Data resource profile: Danish online drug use statistics (MEDSTAT). Int J Epidemiol. 2016;45:1401\u20131402g.","journal-title":"Int J Epidemiol"},{"key":"2974_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.117.003811","volume":"10","author":"MB Mortensen","year":"2017","unstructured":"Mortensen MB, Falk E, Schmidt M. Twenty-year nationwide trends in statin utilization and expenditure in Denmark. Circ Cardiovasc Qual Outcomes. 2017;10:e003811.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2974_CR26","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2022) Guidelines for ATC classification and DDD assignment, 2023: Oslo, Norway. Accessed at https:\/\/www.whocc.no\/filearchive\/publications\/2023_guidelines_web.pdf on 31 January 2023."},{"key":"2974_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJM198501173120303","volume":"312","author":"WD Dupont","year":"1985","unstructured":"Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146\u201351.","journal-title":"N Engl J Med"},{"key":"2974_CR28","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/jnci\/djt124","volume":"105","author":"JA Tice","year":"2013","unstructured":"Tice JA, O\u2019Meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K. Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst. 2013;105:1043\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"2974_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12609-009-0021-5","volume":"1","author":"S Vinayak","year":"2009","unstructured":"Vinayak S, Kurian AW. Statins may reduce breast cancer risk, particularly hormone receptor-negative disease. Curr Breast Cancer Rep. 2009;1:148\u201356.","journal-title":"Curr Breast Cancer Rep"},{"key":"2974_CR30","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1016\/S2468-2667(19)30155-0","volume":"4","author":"D Zhu","year":"2019","unstructured":"Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019;4:e553\u201364.","journal-title":"Lancet Public Health"},{"key":"2974_CR31","unstructured":"R Core Team (2013) R: A language and environment for statistical computing. R Core Team, R Foundation for Statistical Computing: Vienna, Austria. Accessed at http:\/\/www.R-project.org\/ on 29 May 2024."},{"key":"2974_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1158\/1055-9965.EPI-15-0654","volume":"25","author":"S Borgquist","year":"2016","unstructured":"Borgquist S, Tamimi RM, Chen WY, Garber JE, Eliassen AH, Ahern TP. Statin use and breast cancer risk in the Nurses\u2019 Health Study. Cancer Epidemiol Biomarkers Prev. 2016;25:201\u20136.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2974_CR33","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10549-019-05185-0","volume":"175","author":"M Hosio","year":"2019","unstructured":"Hosio M, Urpilainen E, Marttila M, Hautakoski A, Arffman M, Sund R, et al. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes. Breast Cancer Res Treat. 2019;175:741\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"2974_CR34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10549-018-4680-7","volume":"169","author":"C Schairer","year":"2018","unstructured":"Schairer C, Freedman DM, Gadalla SM, Pfeiffer RM. Lipid-lowering drugs, dyslipidemia, and breast cancer risk in a Medicare population. Breast Cancer Res Treat. 2018;169:607\u201314.","journal-title":"Breast Cancer Res Treat"},{"key":"2974_CR35","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1158\/1055-9965.EPI-13-0562","volume":"22","author":"P Desai","year":"2013","unstructured":"Desai P, Chlebowski R, Cauley JA, Manson JE, Wu C, Martin LW, et al. Prospective analysis of association between statin use and breast cancer risk in the Women\u2019s Health Initiative. Cancer Epidemiol Biomarkers Prev. 2013;22:1868\u201376.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2974_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/ijc.24536","volume":"126","author":"J Haukka","year":"2010","unstructured":"Haukka J, Sankila R, Klaukka T, Lonnqvist J, Niskanen L, Tanskanen A, et al. Incidence of cancer and statin usage\u2014record linkage study. Int J Cancer. 2010;126:279\u201384.","journal-title":"Int J Cancer"},{"key":"2974_CR37","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/ijc.33869","volume":"150","author":"DS Kim","year":"2022","unstructured":"Kim DS, Ahn HS, Kim HJ. Statin use and incidence and mortality of breast and gynecology cancer: A cohort study using the National Health Insurance claims database. Int J Cancer. 2022;150:1156\u201365.","journal-title":"Int J Cancer"},{"key":"2974_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-3606-2","volume":"5","author":"R Murakami","year":"2016","unstructured":"Murakami R, Chen C, Lyu SY, Lin CE, Tzeng PC, Wang TF, et al. Lovastatin lowers the risk of breast cancer: a population-based study using logistic regression with a random effects model. Springerplus. 2016;5:1932.","journal-title":"Springerplus"},{"key":"2974_CR39","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1158\/1055-9965.EPI-13-0414","volume":"22","author":"JA McDougall","year":"2013","unstructured":"McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev. 2013;22:1529\u201337.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2974_CR40","doi-asserted-by":"publisher","first-page":"pkab080","DOI":"10.1093\/jncics\/pkab080","volume":"5","author":"MT Marrone","year":"2021","unstructured":"Marrone MT, Mondul AM, Prizment AE, Couper D, Barber JR, Chappidi MR, et al. Lipid-lowering drug use and cancer incidence and mortality in the ARIC Study. JNCI Cancer Spectr. 2021;5:pkab080.","journal-title":"JNCI Cancer Spectr"},{"key":"2974_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-409","volume":"11","author":"Y Vinogradova","year":"2011","unstructured":"Vinogradova Y, Coupland C, Hippisley-Cox J. Exposure to statins and risk of common cancers: a series of nested case-control studies. BMC Cancer. 2011;11:409.","journal-title":"BMC Cancer"},{"key":"2974_CR42","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1158\/0008-5472.CAN-10-2953","volume":"71","author":"EJ Jacobs","year":"2011","unstructured":"Jacobs EJ, Newton CC, Thun MJ, Gapstur SM. Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort. Cancer Res. 2011;71:1763\u201371.","journal-title":"Cancer Res"},{"key":"2974_CR43","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1158\/1055-9965.EPI-10-0524","volume":"19","author":"S Woditschka","year":"2010","unstructured":"Woditschka S, Habel LA, Udaltsova N, Friedman GD, Sieh W. Lipophilic statin use and risk of breast cancer subtypes. Cancer Epidemiol Biomarkers Prev. 2010;19:2479\u201387.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2974_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/cncr.23129","volume":"112","author":"G Pocobelli","year":"2008","unstructured":"Pocobelli G, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Egan KM. Statin use and risk of breast cancer. Cancer. 2008;112:27\u201333.","journal-title":"Cancer"},{"key":"2974_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/pds.1507","volume":"17","author":"GD Friedman","year":"2008","unstructured":"Friedman GD, Flick ED, Udaltsova N, Chan J, Quesenberry CP Jr., Habel LA. Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf. 2008;17:27\u201336.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2974_CR46","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1158\/1055-9965.EPI-06-0737","volume":"16","author":"DM Boudreau","year":"2007","unstructured":"Boudreau DM, Yu O, Miglioretti DL, Buist DS, Heckbert SR, Daling JR. Statin use and breast cancer risk in a large population-based setting. Cancer Epidemiol Biomarkers Prev. 2007;16:416\u201321.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2974_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/01.ede.0000254694.03027.a1","volume":"18","author":"PF Coogan","year":"2007","unstructured":"Coogan PF, Rosenberg L, Strom BL. Statin use and the risk of 10 cancers. Epidemiology. 2007;18:213\u20139.","journal-title":"Epidemiology"},{"key":"2974_CR48","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1002\/cncr.20271","volume":"100","author":"DM Boudreau","year":"2004","unstructured":"Boudreau DM, Gardner JS, Malone KE, Heckbert SR, Blough DK, Daling JR. The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study. Cancer. 2004;100:2308\u201316.","journal-title":"Cancer"},{"key":"2974_CR49","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/sj.bjc.6600267","volume":"86","author":"JA Kaye","year":"2002","unstructured":"Kaye JA, Meier CR, Walker AM, Jick H. Statin use, hyperlipidaemia, and the risk of breast cancer. Br J Cancer. 2002;86:1436\u20139.","journal-title":"Br J Cancer"},{"key":"2974_CR50","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1158\/1055-9965.EPI-07-0726","volume":"17","author":"AS Kumar","year":"2008","unstructured":"Kumar AS, Benz CC, Shim V, Minami CA, Moore DH, Esserman LJ. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users. Cancer Epidemiol Biomarkers Prev. 2008;17:1028\u201333.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2974_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/1940-6207.CAPR-22-0403","volume":"16","author":"ME Sherman","year":"2023","unstructured":"Sherman ME, Vierkant RA, Masters M, Radisky DC, Winham SJ, Degnim AC, et al. Benign breast disease, NSAIDs, and postmenopausal breast cancer risk in the CPS-II cohort. Cancer Prev Res. 2023;16:175\u201384.","journal-title":"Cancer Prev Res"},{"key":"2974_CR52","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1158\/1940-6207.CAPR-20-0178","volume":"13","author":"ME Sherman","year":"2020","unstructured":"Sherman ME, Vierkant RA, Kaggal S, Hoskin TL, Frost MH, Denison L, et al. Breast cancer risk and use of nonsteroidal anti-inflammatory agents after a benign breast biopsy. Cancer Prev Res. 2020;13:967\u201376.","journal-title":"Cancer Prev Res"},{"key":"2974_CR53","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/cncr.21763","volume":"106","author":"L Gallicchio","year":"2006","unstructured":"Gallicchio L, McSorley MA, Newschaffer CJ, Thuita LW, Huang HY, Hoffman SC, et al. Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease. Cancer. 2006;106:1443\u201352.","journal-title":"Cancer"},{"key":"2974_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mayocp.2015.10.018","volume":"91","author":"A Bardia","year":"2016","unstructured":"Bardia A, Keenan TE, Ebbert JO, Lazovich D, Wang AH, Vierkant RA, et al. Personalizing aspirin use for targeted breast cancer chemoprevention in postmenopausal women. Mayo Clin Proc. 2016;91:71\u201380.","journal-title":"Mayo Clin Proc"},{"key":"2974_CR55","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.clbc.2023.12.008","volume":"24","author":"C Marin","year":"2024","unstructured":"Marin C, Weiss A, Gooch JC. Updates in the surgical management of benign and high-risk breast lesions. Clin Breast Cancer. 2024;24:278\u201385.","journal-title":"Clin Breast Cancer"},{"key":"2974_CR56","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2183\/pjab.86.484","volume":"86","author":"A Endo","year":"2010","unstructured":"Endo A. A historical perspective on the discovery of statins. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:484\u201393.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"2974_CR57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-030-20301-6_2","volume":"1152","author":"SS Coughlin","year":"2019","unstructured":"Coughlin SS. Epidemiology of breast cancer in women. Adv Exp Med Biol. 2019;1152:9\u201329.","journal-title":"Adv Exp Med Biol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-02974-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-02974-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-02974-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T10:05:01Z","timestamp":1745921101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-02974-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,5,18]]}},"alternative-id":["2974"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-02974-x","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,8]]},"assertion":[{"value":"29 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SB reported giving lectures for colleagues at events funded by Pfizer and Gedeon Richter. SA reported receiving honoraria for lectures from AstraZeneca. YB reported an agreement on receiving honoraria for lectures from AstraZeneca. LM reported having an immediate family member who is employed at Novo Nordisk and an immediate family member who owns stocks in Novo Nordisk. CS, DCF, JHV, LR, AL, JM, KF, and SF reported no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with relevant guidelines and regulations. The study is recorded in the local archives list of the Danish Cancer Institute (DCS-DCRC-2100). According to Danish regulations, ethical approval and informed consent are not required for purely register-based studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}